Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/05/25 → 7/05/30 |
Clinical Trial Phase
- Phase I
A Phase 1, Open-Label Dose Escalation and Expansion Study of SNV4818 as Monotherapy or in Combination with other Anticancer Agents in Participants with Advanced Solid Tumors
- Frentzas, Sophia (Primary Chief Investigator (PCI))
Project: Research